{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:17:16Z","timestamp":1761556636387,"version":"build-2065373602"},"reference-count":56,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004035","name":"Jordan University of Science and Technology","doi-asserted-by":"publisher","award":["404-2014"],"award-info":[{"award-number":["404-2014"]}],"id":[{"id":"10.13039\/501100004035","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.sapharm.2016.05.050","type":"journal-article","created":{"date-parts":[[2016,6,3]],"date-time":"2016-06-03T09:23:54Z","timestamp":1464945834000},"page":"553-563","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Translation and validation of the Arabic version of generic medicines scale"],"prefix":"10.1016","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3143-5026","authenticated-orcid":false,"given":"Qais","family":"Alefan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aseel","family":"Karasneh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faris","family":"El-Dahiyat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohd","family":"Alshara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dania","family":"Abu-Naser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.sapharm.2016.05.050_bib1","series-title":"The Global Use of Medicines: Outlook Through 2017","first-page":"5","author":"Rickwood","year":"2013"},{"key":"10.1016\/j.sapharm.2016.05.050_bib2","unstructured":"World Health organisation (WHO): Generic Drugs. http:\/\/www.who.int\/trade\/glossary\/story034\/en\/index.html; Accessed 24.05.16."},{"key":"10.1016\/j.sapharm.2016.05.050_bib3","unstructured":"Food and Drug Administration (FDA): Facts about Generic Drugs Infographic. http:\/\/www.fda.gov\/Drugs\/ResourcesForYou\/Consumers\/BuyingUsingMedicineSafely\/UnderstandingGenericDrugs\/ucm167991.htm; Accessed 24.05.16."},{"key":"10.1016\/j.sapharm.2016.05.050_bib4","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1071\/AH042710039","article-title":"Generic drugs: international trends and policy developments in Australia","volume":"27","author":"Lofgren","year":"2004","journal-title":"Aust Health Rev"},{"key":"10.1016\/j.sapharm.2016.05.050_bib5","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/pds.626","article-title":"Generic substitution? Issues relating to the Australian experience","volume":"10","author":"McGavock","year":"2001","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.sapharm.2016.05.050_bib6","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.jacc.2011.06.001","article-title":"ACCF\/AHA 2011 health policy statement on therapeutic interchange and substitution","volume":"58","author":"Holmes","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.sapharm.2016.05.050_bib7","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s11606-006-0074-3","article-title":"What's in a name? Use of brand versus generic drug names in United States outpatient practice","volume":"22","author":"Steinman","year":"2007","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.sapharm.2016.05.050_bib8","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/j.1365-2125.2011.03987.x","article-title":"Generic and therapeutic substitution: a viewpoint on achieving best practice in Europe","volume":"72","author":"Johnston","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.sapharm.2016.05.050_bib9","doi-asserted-by":"crossref","first-page":"w61","DOI":"10.1377\/hlthaff.25.w61","article-title":"Health spending projections through 2015: changes on the horizon","volume":"25","author":"Borger","year":"2006","journal-title":"Health Aff"},{"key":"10.1016\/j.sapharm.2016.05.050_bib10","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1001\/jama.288.14.1773","article-title":"Pharmacy benefit plans and prescription drug spending","volume":"288","author":"Steinwachs","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.sapharm.2016.05.050_bib11","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1093\/heapol\/11.2.198","article-title":"Potential savings from generic prescribing and generic substitution in South Africa","volume":"11","author":"Karim","year":"1996","journal-title":"Health Policy Plan"},{"key":"10.1016\/j.sapharm.2016.05.050_bib12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/20786204.2009.10873809","article-title":"Potential cost savings from generic drugs-protecting the prescribed minimum benefits","volume":"51","author":"Nicolosi","year":"2009","journal-title":"SA Fam Pract"},{"key":"10.1016\/j.sapharm.2016.05.050_bib13","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1001\/archinte.166.3.332","article-title":"The implications of choice","volume":"166","author":"Shrank","year":"2006","journal-title":"Arch Intern Med"},{"year":"2012","series-title":"Jordan National Health Accounts 2009. Technical Report No. 3","key":"10.1016\/j.sapharm.2016.05.050_bib14"},{"year":"2008","series-title":"Medicine Prices, Availability and Affordability and Price Components. A Synthesis Report of Medicine Price Surveys Undertaken in Selected Countries of the WHO Eastern Mediterranean Region","key":"10.1016\/j.sapharm.2016.05.050_bib15"},{"year":"2010","series-title":"Cost Savings of Switching Private Sector Consumption from Originator Brand Drugs to Generic Equivalents","author":"Cameron","key":"10.1016\/j.sapharm.2016.05.050_bib16"},{"key":"10.1016\/j.sapharm.2016.05.050_bib17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/2052-3211-6-3","article-title":"Evaluating patients' perceptions regarding generic drugs in Jordan","volume":"6","author":"El-Dahiyat","year":"2013","journal-title":"J Pharm Policy Pract"},{"year":"2008","series-title":"Measuring Medicine Prices, Availability, Affordability and Price Components","key":"10.1016\/j.sapharm.2016.05.050_bib18"},{"year":"2002","series-title":"Jordanian Civil Health Insurance Regulations: Jordanian Public Health Law no.54. 83\/2002","key":"10.1016\/j.sapharm.2016.05.050_bib19"},{"key":"10.1016\/j.sapharm.2016.05.050_bib20","first-page":"324","article-title":"Patients attitudes towards experience with use of generics in Slovakia, performance of generic substitution","volume":"109","author":"Palagyi","year":"2008","journal-title":"Bratisl Lek Listy"},{"key":"10.1016\/j.sapharm.2016.05.050_bib21","doi-asserted-by":"crossref","first-page":"472","DOI":"10.5414\/CPP43472","article-title":"What do primary care patients think about generic drugs?","volume":"43","author":"Himmel","year":"2005","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.sapharm.2016.05.050_bib22","first-page":"93","article-title":"A pilot survey on perceptions and knowledge of generic drugs among consumers in Penang, Malaysia","volume":"6","author":"Al-Gedadi","year":"2008","journal-title":"Pharm Pract"},{"key":"10.1016\/j.sapharm.2016.05.050_bib23","first-page":"257","article-title":"Generic drugs: perceptions of consumers in Melbourne, Australia","volume":"13","author":"Hassali","year":"2005","journal-title":"I J Pharm Pract"},{"key":"10.1016\/j.sapharm.2016.05.050_bib24","first-page":"20","article-title":"Consumers' Perception of generic drugs in community pharmacies in Malaysia","volume":"2","author":"Thomas","year":"2009","journal-title":"South Med Rev"},{"year":"2006","series-title":"IMS Health, \u201cIMS Health Reports\u201d. A Message from Kathleen Jaeger: It Pays to Invest in Generics","author":"Jaeger","key":"10.1016\/j.sapharm.2016.05.050_bib25"},{"key":"10.1016\/j.sapharm.2016.05.050_bib26","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1377\/hlthaff.28.2.546","article-title":"Patients' perceptions of generic medications","volume":"28","author":"Shrank","year":"2009","journal-title":"Health Aff"},{"key":"10.1016\/j.sapharm.2016.05.050_bib27","first-page":"70","article-title":"Professional practices and perception towards rational use of medicines according to WHO methodology in United Arab Emirates","volume":"8","author":"Abdul Rasool","year":"2010","journal-title":"Pharm Pract"},{"key":"10.1016\/j.sapharm.2016.05.050_bib28","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4103\/2278-0521.112626","article-title":"Consumers\u2032 perceptions on generic drugs in Taif city, Saudi Arabia","volume":"2","author":"Albarraq","year":"2013","journal-title":"Saudi J Health Sci"},{"key":"10.1016\/j.sapharm.2016.05.050_bib29","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1080\/13548500802613043","article-title":"Assessing lay beliefs about generic drugs: development of the generic drugs scale","volume":"14","author":"Figueiras","year":"2009","journal-title":"Psychol Health Med"},{"key":"10.1016\/j.sapharm.2016.05.050_bib30","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1365-2753.2010.01434.x","article-title":"Translation, adaptation and validation of instruments or scales for use in cross-cultural health care research: a clear and user-friendly guideline","volume":"17","author":"Sousa","year":"2011","journal-title":"J Eval Clin Pract"},{"key":"10.1016\/j.sapharm.2016.05.050_bib31","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1524-4733.2005.04054.x","article-title":"Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR task force for translation and cultural adaptation","volume":"8","author":"Wild","year":"2005","journal-title":"Value Health"},{"key":"10.1016\/j.sapharm.2016.05.050_bib32","first-page":"294","article-title":"Generic substitution in Jamaica: challenges to improving effectiveness","volume":"21","author":"Gossell-Williams","year":"2007","journal-title":"WHO Drug Inf"},{"key":"10.1016\/j.sapharm.2016.05.050_bib33","first-page":"474","article-title":"Patients' beliefs about generic medicines in Malaysia","volume":"12","author":"Wong","year":"2014","journal-title":"Pharm Pract"},{"key":"10.1016\/j.sapharm.2016.05.050_bib34","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.healthpol.2011.10.001","article-title":"Underuse of generic drugs in Portugal: an empirical study on the perceptions and attitudes of patients and pharmacists","volume":"104","author":"Quintal","year":"2012","journal-title":"Health Policy"},{"key":"10.1016\/j.sapharm.2016.05.050_bib35","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/j.1432-2277.2011.01268.x","article-title":"A survey to determine the views of renal transplant patients on generic substitution in the Uk","volume":"24","author":"Al Ameri","year":"2011","journal-title":"Transpl Int"},{"key":"10.1016\/j.sapharm.2016.05.050_bib36","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.healthpol.2010.07.006","article-title":"Patients' attitudes towards generic drug substitution in Japan","volume":"99","author":"Kobayashi","year":"2011","journal-title":"Health Policy"},{"key":"10.1016\/j.sapharm.2016.05.050_bib37","first-page":"1","article-title":"Patient knowledge, perceptions, and acceptance of generic drugs: a comprehensive review of the current literature","volume":"6","author":"Alrasheedy","year":"2014","journal-title":"Patient Intell"},{"key":"10.1016\/j.sapharm.2016.05.050_bib38","unstructured":"What Are You Really Measuring? Reliability and Validity in Questionnaire Design. Data Analysis Australia. http:\/\/www.daa.com.au\/analytical-ideas\/questionnaire-validity\/; Accessed 24.05.16."},{"key":"10.1016\/j.sapharm.2016.05.050_bib39","doi-asserted-by":"crossref","first-page":"2","DOI":"10.5539\/gjhs.v1n1p2","article-title":"Developing and validating a questionnaire to measure spirituality: a psychometric process","volume":"1","author":"Parsian","year":"2009","journal-title":"Glob J Health Sci"},{"key":"10.1016\/j.sapharm.2016.05.050_bib40","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1547-5069.2007.00161.x","article-title":"A psychometric toolbox for testing validity and reliability","volume":"39","author":"DeVon","year":"2007","journal-title":"J Nurs Scholarsh"},{"year":"2012","series-title":"Developing and Validating Multiple-choice Test Items","author":"Haladyna","key":"10.1016\/j.sapharm.2016.05.050_bib41"},{"key":"10.1016\/j.sapharm.2016.05.050_bib42","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1207\/s15327906mbr2502_4","article-title":"Structural model evaluation and modification: an interval estimation approach","volume":"25","author":"Steiger","year":"1990","journal-title":"Multivar Behav Res"},{"key":"10.1016\/j.sapharm.2016.05.050_bib43","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1037\/0033-2909.107.2.238","article-title":"Comparative fit indexes in structural\u00a0equation models","volume":"107","author":"Bentler","year":"1990","journal-title":"Psychol Bull"},{"key":"10.1016\/j.sapharm.2016.05.050_bib44","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1037\/0033-2909.88.3.588","article-title":"Significance tests and goodness of fit in the analysis of covariances structures","volume":"88","author":"Bentler","year":"1980","journal-title":"Psychol Bull"},{"key":"10.1016\/j.sapharm.2016.05.050_bib45","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF02310555","article-title":"Coefficient alpha and the internal structure of tests","volume":"16","author":"Cronbach","year":"1951","journal-title":"Psychometrika"},{"key":"10.1016\/j.sapharm.2016.05.050_bib46","article-title":"Cronbach's alpha: a tool for assessing the reliability of scales","volume":"37","author":"Reynaldo","year":"1999","journal-title":"Extention Inf Technol"},{"key":"10.1016\/j.sapharm.2016.05.050_bib47","first-page":"1","article-title":"Translation and validation of the Malaysian version of generic drugs scale","volume":"14","author":"Wong","year":"2014","journal-title":"J Med Mark"},{"key":"10.1016\/j.sapharm.2016.05.050_bib48","doi-asserted-by":"crossref","first-page":"53","DOI":"10.5116\/ijme.4dfb.8dfd","article-title":"Making sense of Cronbach's alpha","volume":"2","author":"Tavakol","year":"2011","journal-title":"Int J Med Educ"},{"key":"10.1016\/j.sapharm.2016.05.050_bib49","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s11096-010-9402-0","article-title":"An evaluation of consumers' knowledge, perceptions and attitudes regarding generic drugs in Auckland","volume":"32","author":"Babar","year":"2010","journal-title":"Pharm World Sci"},{"key":"10.1016\/j.sapharm.2016.05.050_bib50","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.healthpol.2006.10.006","article-title":"Customers' and physicians' opinions of and experiences with generic substitution during the first year in Finland","volume":"82","author":"Heikkil\u00e4","year":"2007","journal-title":"Health Policy"},{"key":"10.1016\/j.sapharm.2016.05.050_bib51","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1211\/ijpp\/17.02.0002","article-title":"Consumers' views on generic drugs: a review of the literature","volume":"17","author":"Hassali","year":"2009","journal-title":"Int J Pharm Pract"},{"key":"10.1016\/j.sapharm.2016.05.050_bib52","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1007\/s11096-008-9247-y","article-title":"People's views on the level of agreement of generic drugs for different illnesses","volume":"30","author":"Figueiras","year":"2008","journal-title":"Pharm World Sci"},{"key":"10.1016\/j.sapharm.2016.05.050_bib53","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.healthpol.2012.04.015","article-title":"Policies to promote use of generic drugs in low and middle income countries: a review of published literature, 2000-2010","volume":"106","author":"Kaplan","year":"2012","journal-title":"Health Policy"},{"key":"10.1016\/j.sapharm.2016.05.050_bib54","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/jphs.12072","article-title":"Malaysian generic pharmaceutical industries: perspective from healthcare stakeholders","volume":"5","author":"Wong","year":"2014","journal-title":"J Pharm Health Serv Res"},{"key":"10.1016\/j.sapharm.2016.05.050_bib55","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.sapharm.2009.12.003","article-title":"Consumer perception on generic drugs in Basrah, Iraq: preliminary findings from a qualitative study","volume":"7","author":"Sharrad","year":"2011","journal-title":"Res Soc Adm Pharm"},{"key":"10.1016\/j.sapharm.2016.05.050_bib56","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00228-010-0935-x","article-title":"Norwegian patients on generic antihypertensive drugs: a qualitative study of their own experiences","volume":"67","author":"Toverud","year":"2011","journal-title":"Eur J Clin Pharmacol"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741116301012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741116301012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:12:41Z","timestamp":1761556361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551741116301012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S1551741116301012"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2016.05.050","relation":{},"ISSN":["1551-7411"],"issn-type":[{"type":"print","value":"1551-7411"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Translation and validation of the Arabic version of generic medicines scale","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2016.05.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}